Scope of U.S. Patent 7,517,334 Claims and U.S. Patent Landscape for a Medication Dispensing Apparatus With Piston-Driven Dose Metering and Post-Dose Plunger Lockout
U.S. Patent 7,517,334 claims a mechanically actuated medication dispensing apparatus that meters a dose by advancing a piston in a fluid container in response to distal movement of a drive member, shifts a plunger element using a pivotal two-pinion gear set with proximal and distal racks, and then performs a dose-preparation-to-final-dose transition that moves a skid relative to a latching lip so a spring-biased latching lip engages a latchable element on the plunger to physically lock the plunger after final administration.
What does claim 1 of U.S. 7,517,334 cover for a medication dispensing apparatus?
Claim 1 is a layered apparatus claim covering: (i) a dose-volume metering mechanism driven by a distal force path, (ii) mechanical translation/gear conversion of the drive member into plunger shifting, and (iii) a positive mechanical interlock that prevents additional dose preparing/injecting after a final dose.
Core structural elements and how they interact (claim 1 mapping)
A. Housing and distal drive member
- The apparatus has a housing.
- A drive member is “within said housing and movable in a distal direction.”
This establishes a linear distal actuation path for the whole dose cycle.
B. Fluid container with a piston and an outlet
- A fluid container defines a medicine-filled reservoir.
- The container has a movable piston at one end and an outlet at the other.
- The piston is engaged by the drive member.
- The piston is advanced toward the outlet a distance equal to distal movement of the drive member.
This is a tight mechanical ratio requirement: the drive member’s distal stroke determines piston displacement.
C. Plunger element
- A plunger element is part of the dose cycle control, and it becomes physically locked after final dosing.
- The claim ties plunger shifting to the gear/rack system and then ties the lock to a latch on/with that plunger element.
D. Gear set with first and second pinions, pivotal on the plunger
- The claim requires:
- a gear set including first and second pinions,
- where the gear set is pivotal on said plunger element,
- and shiftable proximally and distally with the plunger element.
So the gear set is not merely rotating; it is mounted in a way that moves axially with the plunger and pivots as the mechanism advances.
E. First and second racks, one stationary, one movable via a clutch connection
- First rack:
- engaged with first pinion
- and axially stationary within said housing.
- Second rack:
- engaged with second pinion
- and movable within said housing on a piece that is “clutchably connected to said drive member.”
This creates a two-rack architecture: one rack fixes one degree of gear movement, while the other rack follows the drive member through a clutch.
F. Latching element with latching lip and skid; “dose preparing prior to final administration” vs “final dose administration”
The claim introduces a state-dependent latch.
- A latching element includes:
- a latching lip
- and a skid
- The drive member has an axially extending, skid-engaging surface.
- The skid is slidable along that surface as the drive member passes distally.
- The skid-engaging surface has:
- an axial length
- a proximal end
- The drive member and skid are arranged such that, during “dose preparing and injecting prior to a final dose administration”:
- the drive member along the axial length maintains the latching lip against a spring force in a first position,
- and a latchable element disposed on said plunger element remains unengaged.
G. Post-final-dose lock through skid passing the proximal end
- After a “final dose” is administered:
- the skid-engaging surface shifts distally of said skid
- so the skid “passes beyond the proximal end”
- allowing the latching lip to be urged by the spring force from:
- first position to second position
- resulting in engagement with the latchable element:
- “physically lock said plunger element to prevent further dose preparing and injecting.”
The claim’s inventive logic is the sequencing: latch is mechanically held open during dose cycle preparation/injection, then released after final dosing to lock further plunger movement.
Which claim limitations are likely the enforceable “heart” of U.S. 7,517,334?
From a claim-construction and infringement perspective, claim 1’s likely determinative limitations are the combination that ties together (1) dose-volume piston linkage to drive stroke, (2) the two-pinon two-rack gear architecture, and (3) the state-dependent latching lip release triggered by the skid passing a proximal end.
High-probability “heart” limitations in claim 1
- Piston displacement equals drive member distal movement
“advanced toward said outlet a distance equal to a distal movement of said drive member”
- Two-pinon gear set pivotal on plunger and axially shifting with plunger
including “first and second pinions” and “gear set pivotal on said plunger element”
- First rack stationary; second rack movable via clutch connection to drive member
- Skid-engaging surface maintains latching lip against spring force in first position during dose preparing/injecting prior to final dose
- Skid passes beyond proximal end during final administration to release latching lip to second position to lock plunger
- Latchable element disposed on the plunger element
These limitations are not interchangeable with generic “mechanical safety” features; the claim requires a specific release mechanic tied to the skid and the proximal end.
How do dependent claims 2-10 narrow the scope of the lockout and latch geometry?
Dependent claims define implementation details that can create narrower claim sets for infringement and validity positions.
Claim 2: proximal end geometry
- Proximal end of skid-engaging surface comprises a proximal end of the drive member.
This ties the geometry of the engagement feature directly to the drive member end, limiting variants where the proximal end is on another component.
Claim 3: skid location relative to latching lip
- “skid is disposed distally of said latching lip.”
This constrains relative axial layout.
Claim 4: blade skid and flange latching lip
- Skid comprises a blade shape member extending axially.
- Latching lip comprises a transversely extending flange.
This is a structural limitation on cross-sectional forms.
Claim 5: ramped distal face on latchable element
- Latchable element has a ramped distal face over which the latching lip is cammable to reach latching engagement.
This imposes a camming geometry requirement on the latchable element.
Claim 6: latch fixed to housing by flange fit into slot
- Latching element axially fixed to housing by “at least one flange fit into a slot.”
This limits designs where the latch moves relative to the housing.
Claim 7: spring force via resiliency of latching element
- Spring force acting on latching element comprises resiliency of the latching element tending to return latching lip to neutral arrangement.
This makes the “spring” inherent in the latch member rather than an external spring.
Claim 8: one piece metal stamping
- Latching element comprises a one piece metal stamping.
This narrows manufacturing form.
Claim 9: skid-engaging surface smooth
- skid-engaging surface is smooth.
A narrow limitation affecting surface texture.
Claim 10: rim and opening geometry
- latching lip comprises a rim along an opening through which latchable element extends to reach latching engagement.
This constrains the interaction: latchable element extends through an opening rim.
What does the claim set imply about the mechanism’s functional coverage?
Even without the specification text, the claim language strongly implies an apparatus intended to:
- prepare and then administer multiple steps within a single device cycle,
- allow motion during preparation and injection,
- then lock a plunger after the final dose, preventing “further dose preparing and injecting.”
This is functionally consistent with “single-use” or “anti-reuse” mechanisms in medication delivery devices, achieved through axial sequencing of a latch release mechanism.
How strong is the patent estate for U.S. 7,517,334 based on the claim scope alone?
Based on claim structure alone, the strength appears to be in:
- specific mechanical interlock sequencing (skid passing proximal end to release latch after final dose),
- multi-part dose drive linkage (piston displacement tied to drive stroke, plus pivotal gear set on plunger with dual racks),
- geometry constraints available in dependent claims that allow the patentee to argue narrower embodiments if broader combinations are challenged.
Weakness risk points for enforceability are:
- the claim’s requirement for several tightly coupled structures in a single apparatus (housing + piston + specific gear/rack configuration + specific latch release sequencing),
- potential design-around by changing one of those elements, especially:
- replacing the two-rack two-pinon pivotal gear set architecture,
- changing latch release from a skid/proximal-end release to an alternative cam/ratchet, or
- breaking the “distance equal to distal movement” relationship between drive member and piston.
What kinds of design-arounds are suggested by the claim language?
1) Replace the gear/rack conversion architecture
The claim requires:
- first pinion with stationary rack,
- second pinion with movable rack driven by a clutch-connected piece,
- gear set pivotal on plunger and axially shifting with plunger.
A device that meters dose but uses:
- a different actuator-to-plunger transmission (e.g., lead screw, belt, belt-and-pulley with different constraint points),
- or eliminates the clutch-connected movable rack,
could fall outside the combination of limitations.
2) Change the latch release sequencing
Claim 1 is anchored on:
- skid-engaging surface maintained alignment that holds the latch lip against spring force in first position,
- then releasing when the skid passes the proximal end upon final dose administration.
Alternative lockout mechanisms that do not depend on skid passing a proximal end and do not hold/release a latching lip in the claimed manner can avoid key limitations.
3) Modify the “spring force” implementation
If a design uses a discrete spring rather than resiliency of the latch element, it may still fall under claim 1 if claim 7 is not asserted, but it can avoid narrower dependent claim 7 coverage.
4) Latch geometry substitutions
Claims 4, 5, and 10 constrain specific forms:
- blade skid,
- flange lip,
- ramped face,
- rim/opening.
Designs that keep function but change these geometries can avoid dependent claim scope.
What does the claim set cover in terms of manufacturing and component form factors?
- The latch element can be “one piece metal stamping” (claim 8).
- Skid-engaging surface can be smooth (claim 9).
- Skid can be blade-shaped (claim 4).
These are not required for claim 1, but they show typical embodiments and can matter for validity and infringement arguments against close variants.
How would infringement analysis likely be performed for U.S. 7,517,334?
A standard apparatus infringement assessment for claim 1 would require mapping, element by element:
- Drive member distal movement exists.
- Piston in a medicine reservoir is engaged by drive member.
- Piston advancement distance is equal to drive member distal displacement.
- Plunger element is shifted by a gear set pivotal on plunger.
- Gear set has first and second pinions engaging corresponding first and second racks, with one rack axially stationary and the second rack movable via clutch connection.
- Latching element with latching lip and skid exists.
- Drive member carries axially extending skid-engaging surface along which skid slides.
- During dose preparing/injecting prior to final dose, latch lip is held against a spring force in first position without latching engagement.
- After final dose, skid passes beyond proximal end, releasing lip to second position and engaging latchable element on plunger to lock against further dose preparation/injection.
A design that differs on any one of these core structural/functional requirements can reduce claim 1 infringement probability, even if the device still performs anti-reuse.
U.S. patent landscape and licensing posture: what can be concluded from the claim language provided?
The request is limited to U.S. Patent 7,517,334 and the listed claim text. With that constraint, only the following landscape conclusions can be made from claim scope:
- The patent targets device mechanics, not drug molecules. Licensing and litigation are therefore likely to revolve around device architecture (dose metering train and anti-reuse latch), not pharmaceutical formulation or regimen.
- The claim’s combination suggests it would be asserted against devices with:
- piston-based metering,
- gear-and-rack plunger shifting,
- and an axially sequenced lockout mechanism triggered at final dosing.
No additional landscape facts (other patents in the same family, expiration dates, assignee, prosecution history, litigation docket, or Orange Book status) can be produced solely from the provided claim text.
Key Takeaways
- U.S. Patent 7,517,334 claim 1 covers a piston-advanced, distal-drive medication dispensing apparatus with a pivotal two-pinon gear set and stationary plus movable racks.
- The decisive novelty is a state-dependent anti-reuse lockout: a spring-biased latching lip is held in a first position during dose preparing/injecting prior to final dosing by a skid interacting with a skid-engaging surface, then released when the skid passes a proximal end during final administration to lock the plunger.
- Dependent claims tighten the scope through specific geometries (blade skid, flange lip, ramped latchable face, rim/opening) and specific implementation (latch fixed by flange-in-slot, resiliency-based spring, one-piece metal stamping, smooth skid-engaging surface).
- Design-arounds are most plausible where a challenger can change at least one core element: the gear/rack transmission architecture or the skid/proximal-end latch release sequencing.
FAQs
1) What changes would most easily avoid claim 1 of U.S. 7,517,334?
Changing the transmission away from the claimed two-pinon pivotal gear set with stationary and clutch-driven movable racks, or replacing the skid/proximal-end latch release sequencing that locks the plunger after final dosing.
2) Does claim 1 require the latch to be a one-piece metal stamping?
No. That limitation appears in claim 8 and would narrow only that dependent claim.
3) What is the functional trigger for the latch engagement in claim 1?
The skid passes beyond the proximal end of the skid-engaging surface upon administration of the final dose, allowing the latching lip to move from the spring-held first position to the second locked position.
4) Is the piston advancement relationship to the drive member a strict “equal distance” requirement?
Yes. Claim 1 explicitly requires piston advancement distance equal to the distal movement of the drive member.
5) Can a device that prevents reuse without a skid-engaging surface still infringe?
Not if it does not include the specific skid-engaging surface and skid interaction that maintains the latching lip in the first position and releases it when the skid passes the proximal end.
References
- United States Patent 7,517,334, “Medication dispensing apparatus,” claim set as provided in the prompt.
